info@lightchainbio.com
+41 22 552 72 00
Find us
Written by Mei Liang Belhumeur on Wednesday, 24 April 2024. Posted in News
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody
Read more
